Clinical and histopathological evaluation of sucralfate in prevention of oral mucositis induced by radiation therapy in patients with head and neck malignancies

Oral Oncology

Volumn 36, Issue 1, 2000, Pages 116-120

  Etiz, D ^a   Erkal, H Ş ^a   Serin, M ^a   Kucuk B ^a   Hepari, A ^a   Elhan, A H ^a   Tulunay, Ö ^a   Cakmak A ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Double blind method; Drug therapy; Head and neck neoplasms; Mucous membrane; Prospective studies; Radiation injuries; Radiotherapy; Sucralfate

Indexed keywords

ANALGESIC AGENT; PLACEBO; SUCRALFATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPHAGIA; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; MALE; MOUTH MUCOSA; MUCOSA INFLAMMATION; ORAL DRUG ADMINISTRATION; PAIN; PRIORITY JOURNAL; RADIOTHERAPY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; DOUBLE-BLIND METHOD; GASTROINTESTINAL AGENTS; HEAD AND NECK NEOPLASMS; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; RADIATION INJURIES; STOMATITIS; SUCRALFATE;

EID: 0033991149     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(99)00075-5     Document Type: Article

References (25)

1. Fowler J.F., Lindstrom M.J. Loss of local control with prolongation in radiotherapy. International Journal of Radiation Oncology Biology Physics. 23:1992;457-463.
2. Harari P.M., Fowler J.F. Idealized versus realized overall treatment times. International Journal of Radiation Oncology Biology Physics. 29:1994;209-211.
3. Maciejewski B., Skladowski K., Pilecki B.et al. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer: preliminary report on acute toxicity. Radiotherapy and Oncology. 40:1996;137-145.
4. Epstein J.B., Wong F.L.W. The efficacy of sucralfate suspension in the prevention of oral mucositis due to radiation therapy. International Journal of Radiation Oncology Biology Physics. 28:1994;693-698.
5. Makkonen T.A., Boström P., Vilja P., Joensuu H. Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study. International Journal of Radiation Oncology Biology Physics. 30:1994;177-182.
6. Franzen L., Henriksson R., Littbrand B., Zackrisson B. Effects of sucralfate on mucositis during and following radiotherapy of malignancies in the head and neck region: a double-blind placebo-controlled study. Acta Oncologica. 34:1995;219-223.
7. Meredith R., Salter M., Kim R.et al. Sucralfate for radiation mucositis: results of a double-blind randomized trial. International Journal of Radiation Oncology Biology Physics. 37:1997;275-279.
8. Lievens Y, Haustermans K, Van den Weyngaert D et al. Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial. Radiotherapy and Oncology 1998;47:149-53.
9. Oken M.M., Creech R.H., Tormey D.C.et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology. 5:1982;649-655.
10. Van der Schueren E., Van den Bogaert W., Vanuytsel L., Van Limbergen E. Radiotherapy by multiple fractions per day (MFD) in head and neck cancer: acute reactions of skin and mucosa. International Journal of Radiation Oncology Biology Physics. 19:1990;301-311.
11. World Health Organization. Cancer pain relief and palliative care: report of a WHO expert committee. World Health Organization, Geneva, 1990, p. 1-75.
12. Armitage P, Berry G. Statistical methods in medical research. Blackwell Scientific, Oxford, 1987, p. 296-357.
13. Fleiss JL. Statistical methods for rates and proportions. Wiley, New York, 1981, p. 138-43.
14. Taylor S.G., Murthy A.K., Vannetzel J.M.et al. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. Journal of Clinical Oncology. 12:1994;385-395.
15. Horiot J.C., Bontemps P., van den Bogaert W.et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiotherapy and Oncology. 44:1997;111-121.
16. Dische S., Saunders M., Barrett A., Harvey A., Gibson D., Parmar M. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiotherapy and Oncology. 44:1997;123-136.
17. Al-Sarraf M., LeBlanc M., Giri P.G.S.et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. Journal of Clinical Oncology. 16:1998;1310-1317.
18. Peters L.J., Harrison M.L., Dimery I.W., Fields R., Goepfert H., Oswald M.J. Acute and late toxicity associated with sequential bleomycin-containing chemotherapy regimens and radiation therapy in the treatment of carcinoma of the nasopharynx. International Journal of Radiation Oncology Biology Physics. 14:1988;623-633.
19. Shenep J.L., Kalwinsky D.K., Hutson P.R.et al. Efficacy of oral sucralfate suspension in prevention and treatment of chemotherapy-induced mucositis. The Journal of Pediatrics. 113:1988;758-763.
20. Pfeiffer P., Madsen E.L., Hansen O., May O. Effect of prophylactic sucralfate suspension on stomatitis induced by cancer chemotherapy: a randomized, double-blind cross-over study. Acta Oncologica. 29:1990;171-173.
21. Henriksson R., Franzen L., Littbrand B. Effects of sucralfate on acute and late bowel discomfort following radiotherapy of pelvic cancer. Journal of Clinical Oncology. 10:1992;969-975.
22. Sur R.K., Kochhar R., Singh D.P. Oral sucralfate in acute radiation oesophagitis. Acta Oncologica. 33:1994;61-63.
23. O'Brien P., Franklin C.I., Dear K.B.G. A phase III double-blind randomised study of rectal sucralfate suspension in the prevention of acute radiation proctitis. Radiotherapy and Oncology. 45:1997;117-123.
24. Nagashima R., Yoshida N., Terao N. Sucralfate, a basic aluminum salt of sucrose sulfate: II. inhibition of peptic hydrolysis as it results from sucrose sulfate interaction with protein substrate, serum albumins. Arzneimittelforschung. 29:1979;73-76.
25. Nagashima R., Hirano T. Selective binding of sucralfate to ulcer lesion: I. experiments in rats with acetic acid-induced gastric ulcer receiving unlabelled sucralfate. Arzneimittelforschung. 30:1980;80-83.